H. Lundbeck A/S Newsletter
-
<![CDATA[Inside the Phase 3 MASCOT Trial: Lundbeck’s Push for the First Disease-Modifying MSA Therapy]]>
15 Oct 2025 08:55 GMT
… an investigational monoclonal antibody from Lundbeck, is being developed to … 5-10, in Hawaii, Lundbeck shared details behind its … progressing disorder, and how Lundbeck aims to make studies more … take very seriously at Lundbeck. Nearly every company says …
-
FDA turns down Lundbeck, Otsuka's Rexulti in PTSD on lack of efficacy data
23 Sep 2025 02:33 GMT
… in PTSD, according to Lundbeck and Otsuka.
The partners … evidence of the submission,” Lundbeck and Otsuka said in their … Zoloft alone.
Otsuka and Lundbeck argued that Rexulti and Zoloft … with Alzheimer’s disease dementia.
Lundbeck in February reported (PDF) …
-
FDA Issues CRL to Otsuka and Lundbeck for sNDA of Rexulti
22 Sep 2025 18:07 GMT
… Luthman, executive vice president of Lundbeck Research & Development, … with PTSD.”
Otsuka and Lundbeck receive Complete Response Letter … of adults with PTSD Lundbeck September 20, 2025 https … r/otsuka-and-lundbeck-receive-complete-response-letter- …
-
Anxiety Disorders and Depression Treatment Market Growth and Company Analysis Report 2025-2033 Featuring Abbvie, BMS, Eli Lily & Co, GSK, H. Lundbeck, J&J, Merck, Pfizer, Sanofi-Aventis, Axsome – ResearchAndMarkets.com
12 Sep 2025 17:13 GMT
… Lily & Co
GlaxoSmithKline
H. Lundbeck A/S
Johnson …
-
Lundbeck unveils migraine data for eptinezumab at international congress
11 Sep 2025 12:24 GMT
… relief and improved patient outcomes
Lundbeck has presented new clinical data … of Research & Development at Lundbeck, said: “Patients deserve preventive treatments … long-term.”
These findings reinforce Lundbeck’s commitment to improving outcomes …
-
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine
11 Sep 2025 07:42 GMT
… Research & Development at Lundbeck. "Patients deserve preventive … by migraine, and underscores Lundbeck's commitment to … of Investor Relations
MEEP@lundbeck.com
JSHR@lundbeck.com
+45 … 47;news-releases/lundbeck-showcases-new-clinical-migraine- …
-
Lundbeck Announces Restructuring Plans that will Impact Over 600 International Employees
10 Sep 2025 23:26 GMT
… program. Leadership at Lundbeck explained that move is … they have demonstrated at Lundbeck.”
The company plans … amp; CEO, NewBridge Pharmaceuticals.
Lundbeck states that while this move … neuro-specialty disease franchises.
Lundbeck sharpens commercial focus in …
-
Lundbeck Offloads Assets to Three Partners as it Exits 27 Markets, Leaving 602 Jobless
10 Sep 2025 17:27 GMT
… partners.
In Asia, Lundbeck will partner will Zuellig … and South American territories. Lundbeck expects to complete its … model will also lower Lundbeck’s “operational complexity” … its 2025 financial guidelines.
Lundbeck will retain its commercial …
-
Lundbeck, in major resource reallocation, bows out of 27 markets and lays off 602 staffers
10 Sep 2025 09:49 GMT
… trusted regional partners, while Lundbeck will discontinue its commercial organizations … access to Lundbeck’s medicines for patients,” Lundbeck said.
Lundbeck will continue … .
Following the partnership transition, Lundbeck will still have commercial teams …
-
Lundbeck retreats from dozens of markets, slashing staff
10 Sep 2025 09:59 GMT
… jobs but, according to Lundbeck, "are expected to … marketing, access, and distribution of Lundbeck's medicines – is … Arab Emirates.
That means Lundbeck is maintaining its presence in … serving patients," commented Lundbeck's president and …
About
© 1995-2025